TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 34.50
-0.75 (-2.13%)
Mar 25, 2026, 10:12 AM CST
TCI GENE Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 40.57 | 56.31 | 11.67 | 72.15 | 92.45 |
Depreciation & Amortization | 11.98 | 13.16 | 15.05 | 29.29 | 37.36 |
Other Amortization | - | 0.64 | 0.89 | 0.36 | 0.48 |
Loss (Gain) From Sale of Assets | -0.06 | -7.03 | - | -0.24 | -0.01 |
Loss (Gain) From Sale of Investments | 27.18 | 20.15 | - | - | - |
Loss (Gain) on Equity Investments | 8.12 | 9.35 | 5.86 | 3.45 | - |
Stock-Based Compensation | - | - | - | - | 7.26 |
Provision & Write-off of Bad Debts | -1.86 | 3.27 | 0.09 | 0.53 | 0.32 |
Other Operating Activities | -18.86 | 1.84 | -4.84 | 0.95 | 15.79 |
Change in Accounts Receivable | 53.53 | 3.66 | -31.05 | 44.73 | -72.48 |
Change in Inventory | 25.11 | 10.98 | 2.18 | -25.79 | -1.2 |
Change in Accounts Payable | -14.68 | -35.56 | 15.46 | -11.41 | 18.31 |
Change in Unearned Revenue | 7.14 | -1.51 | -0.33 | -5.5 | -0.96 |
Change in Other Net Operating Assets | 13.16 | -18.31 | 2.87 | 1.84 | 21.86 |
Operating Cash Flow | 151.33 | 56.97 | 17.85 | 110.35 | 119.18 |
Operating Cash Flow Growth | 165.65% | 219.16% | -83.83% | -7.41% | 118.14% |
Capital Expenditures | -0.42 | -2.57 | -2.39 | -13.95 | -22.79 |
Sale of Property, Plant & Equipment | 0.08 | 8.05 | - | 0.79 | 0.9 |
Sale (Purchase) of Intangibles | - | -0.09 | -0.78 | -1.34 | -0.63 |
Investment in Securities | 60.1 | -629.89 | -198.6 | -25 | -5.23 |
Other Investing Activities | -0.08 | 5.16 | -2.1 | -0.49 | 0.81 |
Investing Cash Flow | 59.68 | -619.34 | -203.86 | -40 | -26.95 |
Long-Term Debt Repaid | -6.91 | -6.71 | -6.71 | -8.72 | -5.33 |
Net Debt Issued (Repaid) | -6.91 | -6.71 | -6.71 | -8.72 | -5.33 |
Issuance of Common Stock | - | - | 8.98 | 598.1 | 59.94 |
Common Dividends Paid | -52.92 | -26.46 | -52.92 | -53.65 | - |
Other Financing Activities | - | -2.36 | - | - | - |
Financing Cash Flow | -59.83 | -35.52 | -50.64 | 535.73 | 54.61 |
Foreign Exchange Rate Adjustments | 1.08 | 0.28 | -0.04 | 0.47 | 1.78 |
Net Cash Flow | 152.26 | -597.62 | -236.69 | 606.55 | 148.62 |
Free Cash Flow | 150.91 | 54.4 | 15.46 | 96.4 | 96.39 |
Free Cash Flow Growth | 177.43% | 251.78% | -83.96% | 0.01% | 203.00% |
Free Cash Flow Margin | 55.16% | 15.65% | 4.63% | 22.73% | 22.30% |
Free Cash Flow Per Share | 5.66 | 2.05 | 0.58 | 3.92 | 4.87 |
Cash Interest Paid | - | - | - | 0.1 | - |
Cash Income Tax Paid | - | 9.9 | 3.06 | 17.78 | 9.03 |
Levered Free Cash Flow | 92.09 | 7.31 | -6.98 | 64.93 | 80.59 |
Unlevered Free Cash Flow | 92.97 | 7.62 | -6.24 | 65.47 | 81.11 |
Change in Working Capital | 84.26 | -40.73 | -10.87 | 3.86 | -34.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.